Commit To Buy ARS Pharmaceuticals At $7.50, Earn 16.9% Annualized Using Options
August 02, 2024 at 11:35 AM EDT
Investors eyeing a purchase of ARS Pharmaceuticals Inc (SPRY) shares, but tentative about paying the going market price of $9.94/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2025 put at the $7.50 strike, which has a bid at the time of this writing of 80 cents..